Diclofenac Sodium
Product Images NDC 61145-102

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 61145-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Repharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclo 50mg 180 5 21

The label for Diclofenac Sodium Delayed-Release Tablets USP, 50 mg, from REPHARM LLC. It indicates each delayed-release tablet contains 50 mg of Diclofenac Sodium. The package contains 180 tablets. Instructions include storage at 20° to 25°C in a light-resistant container and keeping medication out of reach of children. The label includes a barcode, manufacturer and distributor information, and a note for pharmacists to dispense with the medication guide.*

FDA Label Image

Diclo 50mg 60 5 21

Label for Diclofenac Sodium Delayed Release Tablets USP containing 50 mg per tablet. The package includes 60 delayed-release tablets. Manufactured by Catalyst Technology, Inc. and distributed by REPHARM Pharmaceuticals. Storage instructions and handling warnings are also provided on the label.*

FDA Label Image

Diclo 50mg 90 5 21

Label for Diclofenac Sodium Delayed-Release Tablets USP, each containing 50 mg of diclofenac sodium. The package contains 90 tablets. Label includes storage instructions, dispensing warnings, and manufacturer information from Repharm Pharmaceuticals.*

FDA Label Image

Diclo 75mg 120 5 21

Label for Diclofenac Sodium Delayed-Release Tablets USP, each tablet containing 75 mg of Diclofenac Sodium. The package contains 120 tablets and is manufactured by Carbóid Technology, Inc. and distributed by Repharm Pharmaceuticals. The label provides storage instructions, dispensing advice, and includes a barcode and the NDC 61145-102-12.*

FDA Label Image

Diclo 75mg 180 5 21

Label of Diclofenac Sodium Delayed Release Tablets USP 75 mg by REPHARM LLC. The label states the strength as 75 mg, contains 180 tablets, and includes storage instructions, dispensing warnings, and barcode. It notes the product is Rx only and advises dispensing with a medication guide.*

FDA Label Image

Diclo 75mg 60 5 21

Label for Diclofenac Sodium Delayed-Release Tablets USP, 75 mg strength, containing 60 tablets. The label specifies the active ingredient Diclofenac Sodium USP, 75 mg per tablet. It includes storage instructions, dispensing warnings, and manufacturer and distributor information from REPHARM LLC.*

FDA Label Image

Figure (Score1)

Diclofenac Sodium Delayed Release tablet, white and round, imprinted with '1017' on one side. The labeler is REPHARM LLC. The image shows the front view of a single tablet without additional packaging or dosage details visible.*

FDA Label Image

Figure (Score2)

Diclofenac Sodium Delayed Release 25 mg tablets in a blister pack. The blister contains 10 white round tablets arranged in two columns of five. The labeler name REPHARM LLC is printed on the blister foil along with the product name and strength. Each tablet is labeled with 'D 25'.*

FDA Label Image

Figure (Structure)

Chemical structure of the active ingredient Diclofenac Sodium, showing two chlorophenyl rings connected by an amino group and a sodium carboxylate substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.